Cyteir Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cyteir Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2023.
  • Cyteir Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 36.1M shares, a 2.06% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 36.1M +730K +2.06% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 36M +689K +1.95% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 35.6M +352K +1% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 35.5M +296K +0.84% Dec 31, 2022 10-Q 2023-11-06
Q3 2022 35.4M +249K +0.71% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 35.3M +1.2M +3.51% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 35.3M Mar 31, 2022 10-Q 2022-05-05
Q4 2021 35.2M +33.2M +1623% Dec 31, 2021 10-K 2023-03-23
Q3 2021 35.1M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 34.1M Jun 30, 2021 10-Q 2021-08-09
Q4 2020 2.04M Dec 31, 2020 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.